Halozyme Therapeutics
HALO
#2108
Rank
A$13.81 B
Marketcap
A$117.45
Share price
3.58%
Change (1 day)
27.33%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): A$1.15 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$1.24 Billion. In 2024 the company made an earning of A$0.80 Billion, an increase over its 2023 earnings that were of A$0.50 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$1.15 B43.97%
2024 A$0.80 B59.94%
2023 A$0.50 B39.94%
2022 A$0.35 B0.16%
2021 A$0.35 B92.2%
2020 A$0.18 B-278.96%
2019 -A$0.11 Billion-9.45%
2018 -A$0.12 Billion-229.51%
2017 A$89.07 M-160.48%
2016 -A$0.15 Billion216.03%
2015 -A$46.61 Million-52.86%
2014 -A$98.86 Million-18.09%
2013 -A$0.13 Billion55.88%
2012 -A$77.43 Million169.94%
2011 -A$28.69 Million-63.44%
2010 -A$78.45 Million-7.19%
2009 -A$84.53 Million15.91%
2008 -A$72.93 Million83.89%
2007 -A$39.66 Million78.1%
2006 -A$22.27 Million16%
2005 -A$19.2 Million45.24%
2004 -A$13.22 Million682.42%
2003 -A$1.69 Million1659.12%
2002 -A$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.83 B 4,242.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.13 B 1,488.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.53 B 2,916.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.15 B 1,119.98%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-A$0.4 Billion-136.20%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$44.5 M-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA